AZN•benzinga•
AstraZeneca's Imfinzi (Durvalumab) In Combination With Chemotherapy Has Been Recommended For Approval In The European Union For Adult Patients With Resectable Non-small Cell Lung Cancer
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga